On Sept. 1, 2021, Judge Drain confirmed Purdue Pharma’s restructuring plan. The plan is the culmination of roughly two years of legal wrangling by 48 states, thousands of municipalities, Indian tribes, and tens of private-side parties, each with a stake in the outcome of the case.

Politicians, advocates and academics have assailed the bankruptcy plan as a travesty of justice because, under the plan, the Sacklers will be released from civil liability and will not be held criminally accountable.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]